VaramirStart free · no cardSign in
DSGN as of Nov 1 · 17:22 ET
DSGNNasdaqPharmaceutical Preparations

Design Therapeutics, Inc. · Brief

Next report

3 days

Nov 4 · after closeest.Q3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
0 of 8≥ implied
avg implied
±37.3%
avg realized
±6.5%
Nov 7 '24±29.6%▲+0.69%×0.02
Mar 10 '25±38.4%▼−1.02%×0.03
May 7 '25±57.6%▲+5.71%×0.10
Aug 7 '25±35.2%▲+7.81%×0.22
Nov 5 '25±40.6%▲+4.89%×0.12
Q1 FY26±38.8%▼−3.66%×0.09
Apr 28 '26±29.8%▲+23.26%×0.78
Q2 FY26±28.1%▲+4.76%×0.17
quarterimplied−60%0+60%realized×
Q2 FY26±28.1%▲+4.76%×0.17
Apr '26±29.8%▲+23.26%×0.78
Q1 FY26±38.8%▼−3.66%×0.09
Nov '25±40.6%▲+4.89%×0.12
Aug '25±35.2%▲+7.81%×0.22
May '25±57.6%▲+5.71%×0.10
2 older reports
Mar '25±38.4%▼−1.02%×0.03
Nov '24±29.6%▲+0.69%×0.02
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 4 report · est.

Bull2 of 3

4disclosed supplier and customer ties in SEC filingsSEC filings
3tracked funds holding DSGNN-PORT · Aug 31 '26

Bear2

8 of 8recent reports where the move came under the options implied rangeEarnings history
6 of 22largest reporting managers cutting their stake in the latest quarter13F · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

DSGN report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 21impliedImplied move: ±36.9% into Nov 4 earnings (Oct 21 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.